The U.S. Food and Drug Administration approved ICOTYDE (icotrokinra) for treating moderate-to-severe plaque psoriasis in adults and pediatric patients 12 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE